Abstract:Fengxia Zhan, 1 Wei Song, 2 Yong Fan, 3 Fangjian Wang, 1 Qian Wang 4, 5 1 Department of Clinical Laboratory, Hospital of Shandong University, Jinan, 250100, People's Republic of China; 2 Key Laboratory of Marine Eco-Environmental Science and Technology, First Institute of Oceanography, Ministry of Natural Resources, Qingdao, 266061, People's Republic of China; 3 Qingdao Mental Health Center, Qingdao University, Qingdao, People's Republic of China; 4 Department of Clinical Laboratory, Qilu Hospital, Shandong University, Jinan, 250012, People's Republic of China; 5 Department of Clinical Laboratory, Qilu Hospital (Qingdao), Shandong University, Qingdao, 266035, People's Republic of China Correspondence: Qian Wang, Email Purpose: Cucurbitacins, which are found in a variety of medicinal plants, vegetables and fruits, were known for their diverse pharmacological and biological activities, including anticancer, anti-oxidative and anti-inflammatory effects. Cucurbitacin E, one of the major cucurbitacins, was recently proved to inhibit inflammatory response. Methods: To explore the therapeutic effects of cucurbitacin E on colitis and the underlying mechanisms, male mice drunk water containing 2.5% dextran sulfate sodium (DSS) to establish colitis model and administrated with cucurbitacin E during and after DSS treatment. The disease activity index was scored and colonic histological damage was observed. Intestinal tight junction and inflammatory response were determined. 16S rRNA and transcriptome sequencing were performed to analyze gut microbiota composition and gene expression, respectively. Results: We found that cucurbitacin E alleviated DSS-induced body weight loss and impaired colonic morphology. Cucurbitacin E decreased the expression of inflammatory cytokines and cell apoptosis, and maintained barrier function. Additionally, cucurbitacin E retrieved DSS-induced alterations in the bacterial community composition. Furthermore, a variety of differentially expressed genes (DEGs) caused by cucurbitacin E were enriched in several pathways including the NFκB and TNF signaling pathways as well as in Th17 cell differentiation. There was a close relationship between DEGs and bacteria such as Escherichia-Shigella and Muribaculaceae. Conclusion: Our results revealed that cucurbitacin E may exert protective effects on colitis via modulating inflammatory response, microbiota composition and host gene expression. Our study supports the therapeutic potential of cucurbitacin E in colitis and indicates that gut microbes are potentially therapeutic targets. Keywords: barrier function, colitis, cucurbitacins, inflammation, microbiota Although factors such as damaged integrity, impaired immune ability, microbial disturbance, genetic susceptibility, and dietary modes have been shown to induce chronic inflammatory responses and cause inflammatory bowel diseases (IBD) including colitis, 1 its etiology remains to be fully elucidated. Nevertheless, the consensus is that the inhibition of intestinal inflammatory responses is effective in alleviating the symptoms of colitis. 2 Therefore, various dietary nutrients with strong anti-inflammatory effects can be used to prevent and treat IBD. Cucurbitacin, which are found in a variety of vegetables and fruits, including cucumber, squash, watermelon, and melon, are attracting increasing interest owing to their wide spectrum of pharmacological and biological activity. 3,4 Cucurbitacin E, an extract produced in abundance from Cucurbitaceae plants, exerts many beneficial effects, including anti-angiogenesis, 5 immunosuppressive 6,7 and antitumor 8 effects. Recently, its potential effects on the inflammatory response have been explored. Cucurbitacin E can inhibit inflammation via decreasing the cytochrome c oxidase subunit II expression and the production of TNF-α, IL-6, and IL-1β in RAW264.7 cells and bronchial epithelial cells treated with lipopolysaccharides. 9,10 Cucurbitacin E also decreases the TNF-α and INF-γ levels by inhibiting the NF-κB pathway in Jurkat T cells. 11 Although these results suggest that cucurbitacin E can directly affect inflammation in vitro, the underlying mechanisms remain to be elucidated. Recently, several studies have reported that the gut microbiota is critically involved in the development and treatment of colonic inflammation. However, the effects of cucurbitacin E on colitis and gut microbes have rarely been reported. Therefore, we conducted this study to explore the effects of cucurbitacin E on colitis caused by dextran sulfate sodium (DSS). Additionally, multi-omics analyses, -Abstract Truncated-

Cucurbitacin IIa Induces Caspase-3-dependent Apoptosis and Enhances Autophagy in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages

Cucurbitacin E Induces Autophagy-Involved Apoptosis in Intestinal Epithelial Cells

Cathelicidin-WA attenuates LPS-induced inflammation and redox imbalance through activation of AMPK signaling.

Cucurbitacin IIb alleviates colitis via regulating gut microbial composition and metabolites

Inflammatory-Dependent Bidirectional Effect of Bile Acids on NLRP3 Inflammasome and Its Role in Ameliorating CPT-11-Induced Colitis.

Cucurbitacin B inhibits growth and induces apoptosis through the JAK2/STAT3 and MAPK pathways in SH‑SY5Y human neuroblastoma cells.

Cucurbitacin IIb induces apoptosis and cell cycle arrest through regulating EGFR/MAPK pathway

Cucurbitacin B induces apoptosis in colorectal cells through reactive oxygen species generation and endoplasmic reticulum stress pathways

Investigation of apoptotic effects of Cucurbitacin D, I, and E mediated by Bax/Bcl‐xL, caspase‐3/9, and oxidative stress modulators in HepG2 cell line

Cucurbitacin I exerts its anticancer effects by inducing cell cycle arrest via the KAT2a-ube2C/E2F1 pathway and inhibiting HepG2-induced macrophage M2 polarization

Cucurbitacin E Alleviates Colonic Barrier Function Impairment and Inflammation Response and Improves Microbial Composition on Experimental Colitis Models

Molecular mechanisms of immunomodulatory activity by polysaccharide isolated from the peels of Citrus unshiu

Acute Cardiac Effects of Nicotine in Healthy Young Adults

Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via Induced Autophagy in Macrophages Infected with Mycobacterium tuberculosis

2-Hydroxycircumdatin C inhibits LPS-induced BV2 cells inflammatory response via down-regulation of TLR4-mediated NF-κB/MAPK and JAK2/STAT3 pathways

Cucurbitacin B attenuates osteoarthritis development by inhibiting NLRP3 inflammasome activation and pyroptosis through activating Nrf2/HO‐1 pathway

Curcumin Promotes Degradation of Inducible Nitric Oxide Synthase and Suppresses Its Enzyme Activity in Raw 264.7 Cells

Cucurbitacin C suppresses the progression of pancreatic ductal adenocarcinoma via inhibition of the cGMP-PKG-VASP axis

Curine Inhibits Macrophage Activation and Neutrophil Recruitment in a Mouse Model of Lipopolysaccharide-Induced Inflammation

Salmonella typhimurium prostatic abscess: a rare cause of persisting dysuria in an AIDS patient.

Arginase II inhibited lipopolysaccharide-induced cell death by regulation of iNOS and Bcl-2 family proteins in macrophages